World Conference Calendar

33841 Conferences

European Antibody Congress

Added by evvnt_Platform on 2017-03-15

Conference Dates:

Start Date Start Date: 2017-10-31
Last Date Last Day: 2017-11-02
Deadline for abstracts/proposals Deadline for abstracts/proposals: 2017-10-30

Conference Contact Info:

Contact Person Contact Person: Katy Scrivener
Email Email: KScrivener@terrapinn.com
Address Address: Congress Center Basel, Messeplatz 21, Basel, 4058, Switzerland
Phone Tel: 2070921178

Conference Description:

Our mission, for every European Antibody Congress, is to bring you the very best speakers from big pharma, biotechs, academia and technology innovators to discuss with you the most exciting breakthroughs when it comes to the discovery and development of antibodies.
Whether that's the newest format of a cancer killing ADC, the most advanced screening technology for mAbs, or the clinical development of a bispecific with promises to treat Alzheimer's disease, we want to give you access to all of this to grow your knowledge, grow your business, and grow your connections.

Prices:
Standard early bird price (before 31st March): EUR 1930,
Academic early bird price (before 31st March): EUR 965.

Speakers: Alain Beck, Senior Director, NBEs Analytical Chemistry, Pierre Fabre, Associate Editor, mAbs, Alain Vertes, Managing Director, NxR Biotechnologies, Alexey Rak, Head of Bio Structure and Biophysics, Sanofi RandD, Alfonso Quintas, Head of Clinical Research, Cell Therapies Unit, GSK, André Choulika, CEO, Cellectis, Andrea Gonzalez-Munoz, Research Associate, MedImmune, Andreas Plückthun, Professor of Biochemistry, Director, Department of Biochemistry, University of Zurich, Annelise Vuidepot, VP, Head of Oncology Pipeline and Research, Immunocore, Carsten Kranz, Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Christian Klein, Head of Oncology Programs, Roche, Christian Rommel, Global Head of Oncology Discovery, Roche, Christoph Merten, Group Leader Microfluidics, European Molecular Biology Laboratory, Christoph Rader, Associate Professor, Department of Immunology and Microbiology, The Scripps Research Institute, Dario Neri, Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich, David Brindley, Senior Research Fellow in Healthcare Translation, Department of Paediatrics, University of Oxford, David Gilham, Vice President of Research and Development, Celyad, David Meininger, Chief Business Officer, Trianni, Feng Wang, Principal Investigator, CaliBR, Frank Walsh, CEO, Ossianix, Gregory Winter, Master of Trinity, Cambridge University, Founder and Co-Director, Bicycle Therapeutics

Time: 9:00 am to 5:00 pm
© 2017 World Conference Calendar. All rights reserved.
About WCC | News | FAQs | Links | Terms and Conditions | Privacy | Contact Us